Xenical Short-Term Switch Odds Slimmer Than Long-Term – Experts
This article was originally published in The Tan Sheet
Executive Summary
Xenical's long-term prospect for switch appears promising, but its chances of being recommended for OTC sale by an upcoming advisory panel are slim, some switch experts say